Rupert Timpl
12Patents
7h-index
15Co-inventors
63Inventor score
Filing activity: Apr 13, 1979 → Aug 27, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4312853A | Radioimmunological determination of procollagen (type III) and procollagen peptide (type III) | Emerging Cross-Sectional Technologies | 49 | Expired |
| US4504587A | Procedure for immunologic determination of procollagen peptide (type III) and procollagen peptide col 1 (type III) together and a process for preparing anti-procollagen peptide col 1 (type III) serum | Emerging Cross-Sectional Technologies | 48 | Expired |
| US4609629A | Process for the immunological determination of proteins in body fluid which display a non-parallel inhibition curve to a reference inhibitor | Emerging Cross-Sectional Technologies | 14 | Expired |
| US4340581A | Process for the immunological determination of basal membrane material and new basal membrane suitable therefor | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7671018B2 | Delivery system for heparin-binding growth factors | Human Necessities | 8 | Expired |
| US4798800A | Process for isolating human globular domain NC1 of basal membrane collagen from human tissue | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5811268A | Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids | Chemistry; Metallurgy | 7 | Expired |
| US5493008A | Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin .gamma.1 chain | Human Necessities | 6 | Expired |
| US5147782A | Process for the isolation of basement membrane proteins from human and animal tissues | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5679583A | Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids | Physics | 6 | Expired |
| US5177020A | Method for the immunological determination of heparan sulfate-proteoglycan and process for the preparation and purification of heparan sulfate-proteoglycan suitable for this purpose from tissues containing basal membrane | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6033863A | Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.